comparemela.com

Latest Breaking News On - Life sciences investing - Page 3 : comparemela.com

Goldman Sachs Asset Management Raises $650M For Life Sciences I Fund, Targets Innovation - Goldman Sachs Gr (NYSE:GS)

The Goldman Sachs Group Inc's (NYSE: GS) Goldman Sachs Asset Management recently 

Goldman-sachs
Marc-nachmann
Amit-sinha
Life-sciences
Goldman-sachs-group-inc
Sachs-asset-management
Life-sciences-investing
Goldman-sachs-asset-management
Life-sciences-investing-group
Nested-therapeutics
Wealth-management

Goldman Sachs closes life sciences investment fund

The closing finished well above its original target and represents one of the largest first-time private life sciences growth funds.

Amit-sinha
Andreessen-horowitz
Goldman-sach
Goldman-sach-life-sciences-investing-group
Nvidia
Amicus-therapeutics
Goldman-sachs
Life-sciences
Goldman-sachs-asset-management
Street-life-sciences
Nested-therapeutics
Rapport-therapeutics

Goldman Sachs gets into biotech investing with new venture fund

BioPharma

Amit-sinha
Life-sciences
Goldman-life-sciences
Goldman-sachs
Dive-brief
Sachs-asset-management
Cure-ventures
Life-sciences-investing
Moma-therapeutics
Nested-therapeutics
Biotech

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics

Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, as well.

Alexandria
Al-iskandariyah
Egypt
David-licata
Lyell-immunopharma
John-glaspy
Martina-mcdermott
Amit-sinha
Neil-obrien
Mark-attanasio
Leonard-presta
Dennis-slamon

TORL BioTherapeutics Raises $158M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Alexandria
Al-iskandariyah
Egypt
California
United-states
Los-angeles
Dennis-slamon
Lynn-seely
Amit-sinha
Lyell-immunopharma
David-licata
Mark-alles

vimarsana © 2020. All Rights Reserved.